A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
Clinical trial NCT01252186 · COMPLETED
Trial details
- NCT number
- NCT01252186
- Sponsor
- Teva Women's Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-12-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.